Hikma acquires rights to generic version of Novartis' Mekinist

ShutterWorx Hikma Pharmaceuticals ( OTCPK:HKMPF ) announced on Thursday that it has acquired the FDA-approved Abbreviated New Drug Application (ANDA) for trametinib tablets, a cancer treatment medication, from Novugen. Trametinib is an orally administered kinase inhibitor used in the treatment of certain cancers. It.